Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

NICE recommends Santhera’s Duchenne muscular dystrophy drug Agamree

Approximately 1,700 patients with the muscle-wasting disorder in England are expected to benefit from the decision

- PMLiVE

Amar Urhekar announced as CEO of Avalere Health

Global strategic partner in healthcare, Avalere Health, is proud to announce the appointment of Amar Urhekar as its new Chief Executive Officer.

- PMLiVE

A Successful Outing at ASH 2024

Medscape has wrapped up their work at this year’s ASH annual meeting in San Diego. During the conference, Medscape hosted 8 symposia that presented the latest data and supported advancing...

Medscape Education

- PMLiVE

Scientific Workshop & Consensus Paper Development: A Customer Story

Launching in a complex market? See how virtual tools can streamline consensus-building and optimize treatment planning in our latest customer story. Discover how we helped endocrinology KOLs achieve consensus on...

Impetus Digital

- PMLiVE

BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney

BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers

BOLDSCIENCE

- PMLiVE

AstraZeneca’s Imfinzi granted FDA approval in limited-stage small cell lung cancer

Small cell lung cancer accounts for approximately 15% of all lung cancer diagnoses

- PMLiVE

Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines

The combined vaccine approach could simplify immunisation practices and lead to higher uptake

- PMLiVE

GSK gains exclusive option on DualityBio’s preclinical ADC in deal worth over $1bn

The candidate leverages DualityBio's platform against a gastrointestinal cancer target

- PMLiVE

Merck and Ridgeback initiate phase 3 study of COVID-19 oral antiviral in high-risk adults

Lagevrio is already available in the US under emergency use authorisation to treat certain cases of COVID-19

- PMLiVE

Health economics training unpacked: A conversation with the trainers

Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma and Medtech teams upskill in key HEOR disciplines and prepare...

Petauri Evidence

Challenges for orphan medicines entering the European market

We explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve patient access.

Petauri Evidence

EcoVadis Gold Medal

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links